Table 4.
Treatments |
||||
---|---|---|---|---|
Control |
Low [F] |
High [F] |
||
Strains | Animals | QF/Clinical | QF/Clinical | QF/Clinical |
A/J | 1 | 12.66/1 | 13.38/1 | 68.05/4 |
2 | 10.35/1 | 12.83/1 | 55.47/4 | |
3 | 11.66/0 | 12.49/2 | 27.11/3 | |
4 | 11.60/0 | 14.67/2 | 31.54/3 | |
5 | 11.51/1 | 13.29/1.5 | 45.87/4 | |
129P3/J | 1 | 11.06/1 | 11.14/0 | 12.39/1 |
2 | 12.06/1 | 11.60/0 | 17.57/1 | |
3 | 11.46/1 | 11.08/1 | 15.94/2 | |
4 | 12.11/1 | 11.22/0 | 15.95/2 | |
5 | 11.45/0 | 10.53/0 | 16.72/3 | |
A/J | Total | 11.56 ± 0.37aA | 13.33 ± 0.37aA | 45.61 ± 7.55bA |
129P3/J | Total | 11.63 ± 0.20aA | 11.1 ± 0.17aA | 15.71 ± 0.88aB |
Distinct uppercase superscripts indicate significant differences between the strains. Distinct lowercase superscripts in the same row indicate significant differences among the treatments for the QF data.